International Journal of Aesthetic Medicine and Health


Research article of International Journal of Aesthetic Medicine and Health Phyisiotherapy as a Treatment of Progressive Spinal Amyotrophy type I: a case report Silva, J.S1, Sousa, J.R2, Rosário, D.D.S3, Sousa, J.R.A4, Piauiense, J.N.F5, Vale, M.B6. 1,4 Residente de Farmácia – UFPA;2Residente de Fisioterapia – UFPA; 3Residentes de Enfermagem – UFPA; 5Residente de Biomedicina – UFPA; 6Mestranda de Saúde da Amazônia–UFPA. Introduction: The Progressive Spinal Amyotrophy is an autosomal recessive hereditary disease characterized by the spinal cord motoneurons degeneration, as the type I the most severe. PURPOSE: To describe a physical therapy treatment in a child with type I Progressive Spinal Amyotrophy. Methodology: Descriptive study of a case report of a patient with Progressive Spinal Amyotrophy in physical treatment at the Hospital Santo Antônio Maria Zaccaria in Bragança, Pará. The data was collected from the medical records and the by caregiver. Results and Discussion: M.C.O.P, 6 years old girl, presents Progressive Spinal Amyotrophy type I, excellent cognition, wheelchair user, presents quadriparesis with little trunk control, degree of muscle strength between 1 and 2 at the Oxford scale, ligament laxity, contractures, thoracolumbar kyphoscoliosis, reduction of range of motion in lower limbs, ineffective cough and Forced Vital Spirometry of 800ml (54%). The child receives multiprofessional treatment with an Orthopedist; Pneumologist; Cardiologist; Child Neurologist and Physical Therapist since she was 2 years old. Her actual physical therapy treatment protocol consists of: active-assisted kinesiotherapy for the limbs, cervical spine and abdomen (2 sets of 10 repetitions), trunk stabilization exercises (2 sets of 1 minute), and pulmonary re-expansion with Infant Voldyne (3 sets of 5 repetitions), 3 times a week. Studies demonstrate the importance of a multidisciplinary treatment in children with muscular atrophy, highlighting the physical therapy in the disease delay, quality of life and survival. As is observed in the present study, the multidisciplinary treatment has ...


Review article of International Journal of Aesthetic Medicine and Health Multidisciplinary assistance to breast cancer the nursing and physiotherapys expertise Souza Leão, B. M. L ¹; Câmara, N. S. ²; Figueirêdo, M. P. G. ³; Oliveira, D. A. L. 4 ¹Student of the Nursing Course; ²Student of the Nursing Course, ³Student of the Physiotherapy, 4Nursing Oncologist / Docent of the Undergraduate Nursing Course – ¹,²,³,4ASCES/UNITA Introduction: The breast cancer is a multifactorial pathology, which strikes especially women, usually after 35 years old, considered a global health problem. In Brazil, it is the second cancer with the most incidence in the feminine population. It is responsible for the death of a great number of women in the country. The treatments for this neoplasm vary from mastectomy, chemotherapy, radiotherapy to hormonotherapy. Objectives: To clarify the nursing and physiotherapy assistance in the breast cancer treatment. Methodology: It is a literature review that uses the data from SciELO, LILACS. To select the articles there were used these inclusion criteria: Portuguese language, published between 2007 and 2017, with free access and being result of the use of keywords (DECS-BIREME): Breast Neoplasm, Nursing, Physiotherapy, being found seven articles. Results and Discussion: Regarding the psychological, physical and social repercussions that this disease causes to the patient’s life, it is evident that a bigger involvement of the health professionals is necessary. The aimed physiotherapy in treating patients previously affected by this neoplasia is the onco-functional one, acting before and after surgeries, which seeks to prevent, preserve and restore the kinetic-functional capacity of the patients; on the other hand, the nursing, will be involved during the whole therapeutic process in which the patient will undergo, the action measures ranging from first, second, third-level and postmortem, focusing on the educational and caregiving nature of the profession. The palliative cares that will ...


Review article of International Journal of Aesthetic Medicine and Health Utilization stem cells and antiangiogenic treatment of age-related macular degeneration (AMD) Silva, V.M1, Santos, G.S2, Silva, J.F.S3, Santos, G.M4, Wanderley, M.C.A5, Godone, R.L.N6 1,2,3,4 Student of Biomedicine Course - UNINASSAU- Caruaru; 5, 6 Professor in Biomedicine Course - UNINASSAU- Caruaru. Introduction: Age-related macular degeneration (AMD) is an increasingly common pathology due to the general aging of the population, and has assumed the dimension of a true public health problem. Currently, the applications of cellular therapies are viable in the repair of the corneous tissue. Angiogenesis inhibitors, however, are a class of drugs most commonly used to block the proliferation of new blood vessels. Advances in the study with stem cells and antiangiogenic have provided expectations in the scientific community, as to its use in regeneration of tissues damaged by degenerative diseases. Objective: To relate the advances in research on AMD with the use stem cells and antiangiogenic as an effective treatment for this pathology. Methodology: Electronic data platforms (MEDLINE, PubMed, Scopus) were consulted from 2011 to 2016, using descriptors: “stem cells”, “macular degeneration”, “AMD” and “antiangiogenic”. Results and Discussion: Clinical studies in adult rats showed that stem cells derived from bone marrow applied to the ocular tissue, activated neurological cells called astrocytes, contributed to the regeneration of this tissue due to trauma. The results correlating antiangiogenic as Bevacizumab were included by ANVISA (Agência Nacional de Vigilância Sanitária) in 2011. Therefore, due to its inhibitory effect of angiogenesis, it has been used in ophthalmologic degenerative diseases such as AMD. The regeneration of ocular tissues, through therapy with stem cells presents problems to be solved, by the different types of embryonic tissues. This differentiation should establish criteria for the best choice of the origin of stem cells. Bevacizumab has been used in the ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1. Avinaba Mukherjee, Sourav Sikdar, Anisur Rahman Khuda-Bukhsh. Evaluation of ameliorative potential of isolated flavonol fractions from Thuja occidentalis in lung cancer cells and in Benzo(a) pyrene induced lung toxicity in mice. International Journal of Traditional and Complementary Medicine, 2016; 1(1): 0001-0013. 
2. Vikas Gupta, Parveen Bansal, Junaid Niazi, Kamlesh Kohli, Pankaj Ghaiye. Anti-anxiety Activity of Citrus paradisi var. duncan Extracts in Swiss Albino Mice-A Preclinical Study. Journal of Herbal Medicine Research, 2016; 1(1): 0001-0006.

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

To ensure the quality of the publications in journals of eSciPub LLC, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

The Review Process mainly includes those steps: Receive a invitation to review, Accept invitation, Review the manuscript, Submit your review. As a reviewer of eSciPub publisher, you will receive our invitation to review a manuscript by e-mail.

Please make sure that you are a expertise within the area of the manuscript and without any conflict of interest with the manuscript you will review. Please keep in mind that manuscripts emailed to reviewers are for the purpose of critical evaluation only. Reviewer must keep manuscripts and the review process confidentially. As a reviewer, he/she should review and return their comments in a timely manner. If you can not submit your comments in the agreed time, please inform us ASAP to avoid any delays.

Once finish the review process of a manuscript, you should submit your comments to eSciPub editors. The specific recommendations are as follows:

• Accept

• Minor revision

• Moderate revision

• Major revision

• Reject

Open Access

International Journal of Aesthetic Medicine and Health (ISSN:2637-630X; DOI:10.28933/IJAMH) is a peer reviewed open access journal publishing research manuscripts, review articles, editorials, letters to the editor in Aesthetic Medicine and Health (Indexing details).

Peer Review

To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication

Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days.  More details....

Rapid Response Team

Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions shortly.

#1-International Journal of Aesthetic Medicine